StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Chandan Taparia, Motilal Oswal

BUYSun Pharmaceutical Industries Ltd.

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))24 Jul 2026via LiveMint Markets

Entry₹1,954Inferred
Target₹2,070
Total upside +5.94% (call closed)
Stop loss₹1,890-3.28% risk
At expiry₹1,9516 Aug 2026, 3:30 pm
Expired-0.15%auction close
Follow Chandan Taparia for new calls(35% target hit, 164 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 185 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 6 Aug 2026
7 supporting2 neutral3 opposing
Supports the BUY call (7)

Sun Pharma has received approval to manufacture and market semaglutide in Brazil, indicating a potential market expansion and new product offering.

BSE · Company Update·29 Jul · 1w ago

(opens in new tab)

3 advisors have active short-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · adjacent horizon·30 Jul · 1w ago

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·29 Jul · 1w ago

Sun Pharma announced that Organon shareholders have approved the proposed acquisition, moving forward the company's strategic expansion plans.

BSE · Company Update·24 Jul · 2w ago

(opens in new tab)

Sun Pharmaceutical Industries advances Tuesday, outperforms market

NewsGoogle News·21 Jul · 2w ago

(opens in new tab)
Neutral / worth noting (2)

CRISIL has removed the 'Rating Watch with Developing Implications' status and reaffirmed Sun Pharma's long-term bank facilities rating at 'CRISIL AAA/Stable'.

BSE · Company Update·5 Aug · yesterday

(opens in new tab)

Unaudited Standalone and Consolidated Financial Results for Q1 of FY 2026-27

NSE · Outcome of Board Meeting·31 Jul · 6d ago

(opens in new tab)
Weighs against the BUY call (3)

Pharma stocks: Sun Pharma, Biocon, Dr Reddy's, Torrent Pharma slip on Trump's generic drug tariff plan

NewsGoogle News·23 Jul · 2w ago

(opens in new tab)

Indian pharma stocks fall after Trump outlines tariffs on generics

NewsGoogle News·22 Jul · 2w ago

(opens in new tab)

Sun Pharmaceutical Industries falls Friday, outperforms competitors

NewsGoogle News·17 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.